Weight-loss drugs may reduce opioid and alcohol abuse by up to 50%, study finds

Date:

October 17, 2024

Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer greater benefits than just weight and diabetes management.

Source link

Best Soft Mattresses of 2024: Tested and Reviewed

Experts say OpenAI’s patent pledge amounts to little more than ‘virtue signaling’

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Weight-loss drugs may reduce opioid and alcohol abuse by up to 50%, study finds

Recent posts

Powell says Fed doesn’t need to hurry to cut interest rates

Marriage proposals are still falling but should bottom this year, Signet says

A U.S. ‘sovereign wealth fund’? Please, no.

Cava’s stock slides 8% after CEO and other insiders announce stock sales

Tesla’s market cap hits $1 trillion after another Trump-fueled jump for the stock

Bud Light sales extend their drop but Michelob Ultra takes up some slack: report

Parents trust Republicans more on the economy, but they’re split on Trump vs. Harris

Skydance reportedly accuses Paramount committee of violating merger deal

Chipotle to speed up CFO transition after C-suite shakeup

Dollar General’s stock heads for record plunge after a triple miss for earnings

French stocks and bonds slip after deadlocked election

This company’s performance is challenging the traditional definition of meme stocks

Retiree healthcare costs jump almost 5% to $165,000 — more than double the 2002 rate

Want a refund for your delayed or cancelled flight after the CrowdStrike outage? You can get it — here’s the trick.

Stocks are having their best election year since 1976. What the rally needs to continue.

Related articles

Investors are bracing for higher-for-even-longer interest rates

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

Manufacturing activity surges in New York region to highest level in nearly three years

RFK Jr. would rattle health markets as head of HHS, but his confirmation is far from certain, analyst says

Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS

Powell says Fed doesn’t need to hurry to cut interest rates

Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

Off-price retailers could thrive, BofA says, citing this bullish data point

Company

Follow us